128 related articles for article (PubMed ID: 1972185)
1. A quantitative assessment of somatostatin-like and neuropeptide Y-like immunostained cells in the frontal and temporal cortex of patients with Alzheimer's disease.
Davies CA; Morroll DR; Prinja D; Mann DM; Gibbs A
J Neurol Sci; 1990 Apr; 96(1):59-73. PubMed ID: 1972185
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin and neuropeptide Y immunoreactivity in Parkinson's disease dementia with Alzheimer's changes.
Beal MF; Clevens RA; Mazurek MF
Synapse; 1988; 2(4):463-7. PubMed ID: 2903567
[TBL] [Abstract][Full Text] [Related]
3. Widespread deficits in somatostatin but not neuropeptide Y concentrations in Alzheimer's disease cerebral cortex.
Gabriel SM; Bierer LM; Harotunian V; Purohit DP; Perl DP; Davis KL
Neurosci Lett; 1993 May; 155(1):116-20. PubMed ID: 8103205
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin and neuropeptide Y concentrations in pathologically graded cases of Huntington's disease.
Beal MF; Mazurek MF; Ellison DW; Swartz KJ; McGarvey U; Bird ED; Martin JB
Ann Neurol; 1988 Jun; 23(6):562-9. PubMed ID: 2900622
[TBL] [Abstract][Full Text] [Related]
5. The regional distribution of somatostatin and neuropeptide Y in control and Alzheimer's disease striatum.
Beal MF; Mazurek MF; McKee MA
Neurosci Lett; 1987 Aug; 79(1-2):201-6. PubMed ID: 2890123
[TBL] [Abstract][Full Text] [Related]
6. Cortical somatostatin, neuropeptide Y, and NADPH diaphorase neurons: normal anatomy and alterations in Alzheimer's disease.
Kowall NW; Beal MF
Ann Neurol; 1988 Feb; 23(2):105-14. PubMed ID: 2897822
[TBL] [Abstract][Full Text] [Related]
7. Widespread reduction of somatostatin-like immunoreactivity in the cerebral cortex in Alzheimer's disease.
Beal MF; Mazurek MF; Svendsen CN; Bird ED; Martin JB
Ann Neurol; 1986 Oct; 20(4):489-95. PubMed ID: 3789664
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin 28 and neuropeptide Y innervation in the septal area and related cortical and subcortical structures of the human brain. Distribution, relationships and evidence for differential coexistence.
Gaspar P; Berger B; Lesur A; Borsotti JP; Febvret A
Neuroscience; 1987 Jul; 22(1):49-73. PubMed ID: 2888048
[TBL] [Abstract][Full Text] [Related]
9. A comparison of somatostatin and neuropeptide Y distribution in monkey brain.
Beal MF; Mazurek MF; Martin JB
Brain Res; 1987 Mar; 405(2):213-9. PubMed ID: 3567602
[TBL] [Abstract][Full Text] [Related]
10. A comparison of regional somatostatin and neuropeptide Y distribution in rat striatum and brain.
Beal MF; Chattha GK; Martin JB
Brain Res; 1986 Jul; 377(2):240-5. PubMed ID: 3755369
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin and neuropeptide Y are unaltered in the amygdala in schizophrenia.
Beal MF; Svendsen CN; Bird ED; Martin JB
Neurochem Pathol; 1987 Jun; 6(3):169-76. PubMed ID: 2888067
[TBL] [Abstract][Full Text] [Related]
12. Expression of somatostatin receptor subtypes (SSTR1-5) in Alzheimer's disease brain: an immunohistochemical analysis.
Kumar U
Neuroscience; 2005; 134(2):525-38. PubMed ID: 15961235
[TBL] [Abstract][Full Text] [Related]
13. Cortical somatostatinergic system not affected in Alzheimer's and Parkinson's diseases.
Whitford C; Candy J; Edwardson J; Perry R
J Neurol Sci; 1988 Aug; 86(1):13-8. PubMed ID: 2902199
[TBL] [Abstract][Full Text] [Related]
14. Differential sparing of somatostatin-neuropeptide Y and cholinergic neurons following striatal excitotoxin lesions.
Beal MF; Kowall NW; Swartz KJ; Ferrante RJ; Martin JB
Synapse; 1989; 3(1):38-47. PubMed ID: 2563916
[TBL] [Abstract][Full Text] [Related]
15. Effect of cysteamine on somatostatin and neuropeptide Y in rat striatum and cortical synaptosomes.
Chattha GK; Beal MF
Brain Res; 1987 Jan; 401(2):359-64. PubMed ID: 3815102
[TBL] [Abstract][Full Text] [Related]
16. Location of neuronal tangles in somatostatin neurones in Alzheimer's disease.
Roberts GW; Crow TJ; Polak JM
Nature; 1985 Mar 7-13; 314(6006):92-4. PubMed ID: 2858057
[TBL] [Abstract][Full Text] [Related]
17. Decreased somatostatin immunoreactivity but not neuropeptide Y immunoreactivity in cerebral cortex in senile dementia of Alzheimer type.
Dawbarn D; Rossor MN; Mountjoy CQ; Roth M; Emson PC
Neurosci Lett; 1986 Sep; 70(1):154-9. PubMed ID: 2877420
[TBL] [Abstract][Full Text] [Related]
18. Age-related changes of VIP, NPY and somatostatin-immunoreactive neurons in the cerebral cortex of aged rats.
Cha CI; Lee YI; Lee EY; Park KH; Baik SH
Brain Res; 1997 Apr; 753(2):235-44. PubMed ID: 9125408
[TBL] [Abstract][Full Text] [Related]
19. Peptidergic neurons of subcortical white matter in aging and Alzheimer's brain.
Ang LC; Shul DD
Brain Res; 1995 Mar; 674(2):329-35. PubMed ID: 7540926
[TBL] [Abstract][Full Text] [Related]
20. Influence of region-specific alterations of neuropeptidase content on the catabolic fates of neuropeptides in Alzheimer's disease.
Ichai C; Chevallier N; Delaere P; Dournaud P; Epelbaum J; Hauw JJ; Vincent JP; Checler F
J Neurochem; 1994 Feb; 62(2):645-55. PubMed ID: 7905027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
